AIM: To compare the effectiveness of sequential therapy for Helicobacter pylori (H. pylori) infection with that of triple therapy of varying durations. METHODS: The 460 patients enrolled in this study had H. pylori-associated gastritis or a gastric or duodenal ulcer. After screening, H. pylori-infected patients were randomly assigned to receive either conventional triple therapy for 7, 10 or 14 d, or a new 10-d sequential therapy. Each of the 4 treatment groups included 115 patients. The outcomes of eradication therapy were assessed 4 wk after treatment by the urea breath test and histology. RESULTS: The overall eradication rate was 81.0%, and eradication rates were 75.7% for 7-d conventional triple therapy, 81.9% for 10-d conventional triple therapy, 84.4% for 14-d conventional triple therapy, and 82.0% for 10-d sequential therapy. Neither intention-to-treat analysis nor per protocol analysis showed significant differences in eradication rates using sequential therapy or the standard triple therapy (P = 0.416 and P = 0.405, respectively). CONCLUSION: There are no significant differences between 10-d sequential eradication therapy for H. pylori and any duration of standard triple treatment in Korean patients.
RCT Entities:
AIM: To compare the effectiveness of sequential therapy for Helicobacter pylori (H. pylori) infection with that of triple therapy of varying durations. METHODS: The 460 patients enrolled in this study had H. pylori-associated gastritis or a gastric or duodenal ulcer. After screening, H. pylori-infectedpatients were randomly assigned to receive either conventional triple therapy for 7, 10 or 14 d, or a new 10-d sequential therapy. Each of the 4 treatment groups included 115 patients. The outcomes of eradication therapy were assessed 4 wk after treatment by the urea breath test and histology. RESULTS: The overall eradication rate was 81.0%, and eradication rates were 75.7% for 7-d conventional triple therapy, 81.9% for 10-d conventional triple therapy, 84.4% for 14-d conventional triple therapy, and 82.0% for 10-d sequential therapy. Neither intention-to-treat analysis nor per protocol analysis showed significant differences in eradication rates using sequential therapy or the standard triple therapy (P = 0.416 and P = 0.405, respectively). CONCLUSION: There are no significant differences between 10-d sequential eradication therapy for H. pylori and any duration of standard triple treatment in Korean patients.
Authors: Jae Yeon Kim; Na Young Kim; Sung Jung Kim; Gwang Ho Baik; Gwang Ha Kim; Jung Mogg Kim; Ryoung Hee Nam; Hong Bin Kim; Dong Ho Lee; Hyun Chae Jung; In Sung Song Journal: Korean J Gastroenterol Date: 2011-04
Authors: P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers Journal: Gut Date: 2006-12-14 Impact factor: 23.059
Authors: Y S Kim; S J Kim; J H Yoon; K T Suk; J B Kim; D J Kim; D Y Kim; H J Min; S H Park; W G Shin; K H Kim; H Y Kim; G H Baik Journal: Aliment Pharmacol Ther Date: 2011-09-19 Impact factor: 8.171
Authors: Hong Sang Oh; Dong Ho Lee; Ji Yeon Seo; Yu Ri Cho; Nayoung Kim; Sook Hyang Jeoung; Jin Wook Kim; Jin Hyeok Hwang; Young Soo Park; Sang Hyub Lee; Cheol Min Shin; Hyun Jin Cho; Hyun Chae Jung; In Sung Song Journal: J Gastroenterol Hepatol Date: 2012-03 Impact factor: 4.029
Authors: S Koletzko; F Richy; P Bontems; J Crone; N Kalach; M L Monteiro; F Gottrand; D Celinska-Cedro; E Roma-Giannikou; G Orderda; S Kolacek; P Urruzuno; M J Martínez-Gómez; T Casswall; M Ashorn; H Bodanszky; F Mégraud Journal: Gut Date: 2006-04-07 Impact factor: 23.059
Authors: Jung H Kwon; Dong H Lee; Byeong J Song; Jung W Lee; Jin J Kim; Young S Park; Nayoung Kim; Sook-Hyang Jeong; Jin-Wook Kim; Sang H Lee; Jin H Hwang; Hyun C Jung; In S Song Journal: Helicobacter Date: 2010-04 Impact factor: 5.753
Authors: Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme Journal: World J Gastroenterol Date: 2014-08-21 Impact factor: 5.742